COVID-19 in Lymphangioleiomyomatosis An International Study of Outcomes and Impact of Mechanistic Target of Rapamycin Inhibition
Bruno Guedes Baldi
(1)
,
Elzbieta Radzikowska
(2)
,
Vincent Cottin
(2)
,
Daniel Dilling
(3)
,
Ali Ataya
(4)
,
Carlos Roberto Ribeiro Carvalho
(1)
,
Sergio Harari
(5, 6)
,
Matthew Koslow
(7)
,
Jan Grutters
(8)
,
Yoshikazu Inoue
(9)
,
Nishant Gupta
(10)
,
Simon Johnson
(11)
1
USP -
Universidade de São Paulo = University of São Paulo
2 IVPC - Infections Virales et Pathologie Comparée - UMR 754
3 Loyola University [Chicago]
4 UF - University of Florida [Gainesville]
5 UNIMI - Università degli Studi di Milano = University of Milan
6 IRCCS - Istituti di Ricovero e Cura a Carattere Scientifico
7 National Jewish Health Division of Pulmonary, Critical Care and Sleep Medicine
8 Univ Med Ctr Utrecht, Dept Pediat Gastroenterol
9 Kinki University
10 UC - University of Cincinnati
11 UON - University of Nottingham, UK
2 IVPC - Infections Virales et Pathologie Comparée - UMR 754
3 Loyola University [Chicago]
4 UF - University of Florida [Gainesville]
5 UNIMI - Università degli Studi di Milano = University of Milan
6 IRCCS - Istituti di Ricovero e Cura a Carattere Scientifico
7 National Jewish Health Division of Pulmonary, Critical Care and Sleep Medicine
8 Univ Med Ctr Utrecht, Dept Pediat Gastroenterol
9 Kinki University
10 UC - University of Cincinnati
11 UON - University of Nottingham, UK